Verily, an Alphabet subsidiary focused on precision health and AI, has secured $300 million in a Series X funding round. The investment was led by Series X Capital and included participation from Alphabet, UCHealth, and the University of Colorado Anschutz. This funding will support Verily's AI strategy for precision health, with Alphabet now holding a significant minority stake.